Adsorption capabilities of various extracorporeal devices for blood purification in increasing concentration of lipopolysaccharide. (In vitro benchmark experiment on fetal bovine serum)

Babaev M.A.; Dymova O.V.; Matveeva N.A.; Eremenko A.A.

doi:https://doi.org/10.17116/anaesthesiology202105140

Babaev M.A.

Petrovsky National Research Centre of Surgery

Dymova O.V.

Petrovsky National Research Centre of Surgery

Matveeva N.A.

Petrovsky National Research Centre of Surgery

Eremenko A.A.

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

ORCID: 0000-0001-5809-8563

Adsorption capabilities of various extracorporeal devices for blood purification in increasing concentration of lipopolysaccharide. (In vitro benchmark experiment on fetal bovine serum)

Authors:

Babaev M.A., Dymova O.V., Matveeva N.A., Eremenko A.A.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2021;(5): 40‑47

DOI: 10.17116/anaesthesiology202105140

Read: 2703 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Babaev MA, Dymova OV, Matveeva NA, Eremenko AA. Adsorption capabilities of various extracorporeal devices for blood purification in increasing concentration of lipopolysaccharide. (In vitro benchmark experiment on fetal bovine serum). Russian Journal of Anesthesiology and Reanimatology. 2021;(5):40‑47. (In Russ.)
https://doi.org/10.17116/anaesthesiology202105140

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the sorption characteristics of various extracorporeal devices in proportionally increasing concentration of lipopolysaccharide (LPS) in benchmark experimental model on fetal bovine serum.

MATERIAL AND METHODS

A bench experiment was carried out with fetal bovine serum circulating in a closed loop system at a temperature of 37 °C. LPS was injected in serum using a syringe pump at a constant rate of 33 μg per hour for 4 hours. We studied adsorption devices from 6 manufacturers differing in their design (granules, fiber, porous capillary), active adsorption ligand (polyethyleneimine, synthetic peptide, polymyxin B, etc.) and sorption capacities. Endotoxin level was determined using the LAL test before infusion, after 30, 60, 120 and 240 minutes. Sorption characteristics were evaluated using endotoxin adsorption coefficient (EAC).

RESULTS

All devices were able to bind LPS and corresponded to Langmuir isotherm model. However, EAC values differed significantly among the tested products. After 240 minutes, a product based on immobilized polymyxin B showed EAC 70.54%. A membrane of hollow fibers of acrylonitrile and methallyl sulfonate with heparin coating and sorbent based on polysaccharide granular matrix and chemical ligand specific to LPS adsorbed no more than 10.2% and 10.63%, respectively. Adsorption capacity of columns based on multimodal sorbent and device filled with porous polyethylene plates was 6.77 and 8.91%, respectively.

CONCLUSION

It is necessary to consider adsorption coefficient for maximum effect from selective extracorporeal therapy. In this experiment, a cartridge based on immobilized polymyxin B showed the maximum adsorption coefficient (70.54%). Products based on other principles of sorption and active ligands were characterized by adsorption coefficients 6.77—10.63%.

Keywords:

endotoxin

lipopolysaccharide adsorption

hemoperfusion

oXiris

LPS adsorber Alteco

Toxipak

Efferon LPS

Toraymyxin PMX-20R

Authors:

Babaev M.A.

Petrovsky National Research Centre of Surgery

Dymova O.V.

Petrovsky National Research Centre of Surgery

Matveeva N.A.

Petrovsky National Research Centre of Surgery

Eremenko A.A.

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

ORCID: 0000-0001-5809-8563

Received:

12.02.2021

Accepted:

23.03.2021

Close metadata

References:

Yakovlev MYu. Intestinal endotoxin: immunity—inflammation—aging as links in one chain. Patogenez. 2020;18(1):82-94. (In Russ.). https://doi.org/10.25557/2310-0435.2020.01.82-94
Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and «Garb-aging». Trends in Endocrinology and Metabolism: TEM. 2017;28(3):199-212. https://doi.org/10.1016/j.tem.2016.09.005
Anikhovskaya IA, Beloglazov VA, Gordienko AI, Ivanov YuD, Kubyshkin AV, Markelova MM, Pokusayeva DP, Yakovlev MYu. A brief history of studying the role of intestinal factor in aging and/or induction of systemic inflammation: Achievements, challenges, and prospects. Patogenez. 2019;17(1):4-17. (In Russ.). https://doi.org/10.25557/2310-0435.2019.01.4-17
De Rosa S, Villa G, Ronco C. The golden hour of polymyxin B hemoperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis. Artificial Organs. 2020;44(2):184-186. https://doi.org/10.1111/aor.13550
Romaschin AD, Obiezu-Forster CV, Shoji H, Klein DJ. Novel Insights into the Direct Removal of Endotoxin by Polymyxin B Hemoperfusion. Blood Purification. 2017;44(3):193-197. https://doi.org/10.1159/000475982
Munford RS. Endotoxemia-menace, marker, or mistake? Journal of Leukocyte Biology. 2016;100(4):687-698. https://doi.org/10.1189/jlb.3RU0316-151R
Harm S, Falkenhagen D, Hartmann J. Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations? The International Journal of Artificial Organs. 2014;37(3):222-232. https://doi.org/10.5301/ijao.5000304
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Medicine Experimental. 2018;6(1):12. https://doi.org/10.1186/s40635-018-0177-2
Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Critical Care. 2007;11(2):R47. https://doi.org/10.1186/cc5780
Iba T, Fowler L. Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial. Journal of Intensive Care. 2017;5:40. https://doi.org/10.1186/s40560-017-0236-x
Yaroustovsky M, Abramyan M, Komardina E, Nazarova H, Popov D, Plyushch M, Soldatkina A, Rogalskaya E. Selective LPS Adsorption Using Polymyxin B-Immobilized Fiber Cartridges in Sepsis Patients Following Cardiac Surgery. Shock. 2018;49(6):658-666. https://doi.org/10.1097/SHK.0000000000001016
Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Medicine. 2018;44(12):2205-2212. https://doi.org/10.1007/s00134-018-5463-7
Khoroshilov SE, Nikulin AV, Bessonov IV, Morozov AS, Yarema IV. Efficacy and Safety of a Novel Adsorber for LPS-Selective Hemosorption (Experimental Study). Obshchaya reanimatologiya. 2018;14(6):51-60. (In Russ.). https://doi.org/10.15360/1813-9779-2018-6-51-60
Morozov AS, Bessonov IV, Nuzhdina AV, Pisarev VM. Sorbents for Extracorporeal Removal of Toxic Substances and Molecules with Adverse Biological Activity (Review). Obshchaya reanimatologiya. 2016;12(6):82-107. (In Russ.). https://doi.org/10.15360/1813-9779-2016-6-82-107
Rubtsov MS, Shukevich DL. Modern extracorporeal methods for critical conditions caused by systemic inflammatory response (review). Anesteziologiya i reanimatologiya. 2019;4:20-30. (In Russ.). https://doi.org/anaesthesiology201904120
Patiha HE, Heraldy E, Hidayat Y, Firdaus M. The langmuir isotherm adsorption equation: The monolayer approach. IOP Conference Series: Materials Science and Engineering. 2016;107(1)012067. https://doi.org/10.1088/1757-899X/107/1/012067
Vesely DL. Chapter 39. Antinatriureic peptides. Seldin and Giebisch’s the Kidney. Fifth ed. Elsevier Inc.; 2013;1241-1281. https://doi.org/10.1016/B978-0-12-381462-3.00037-9
Monard C, Rimmelé T, Ronco C. Extracorporeal Blood Purification Therapies for Sepsis. Blood Purification. 2019;47(suppl 3):1-14. https://doi.org/10.1159/000499520
Miyamoto K, Kawazoe Y, Kato S. Prolonged direct hemoperfusion using a polymyxin B immobilized fiber cartridge provides sustained circulatory stabilization in patients with septic shock: a retrospective observational before-after study. Journal of Intensive Care. 2017;5:19. https://doi.org/10.1186/s40560-017-0214-3
Yamashita C, Moriyama K, Hasegawa D, Kato Y, Sakai T, Kawaji T, Shimomura Y, Kurimoto Y, Nagata M, Nishida O. In Vitro Study of Endotoxin Adsorption by a Polymyxin B-Immobilized Fiber Column. Blood Purification. 2018;46(4):269-273. https://doi.org/10.1159/000489920
Mitaka C, Fujiwara N, Yamamoto M, Toyofuku T, Haraguchi G, Tomita M. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period. Journal of Critical Care. 2014;29(5):728-732. https://doi.org/10.1016/j.jcrc.2014.03.031
Babaev MA, Shalginskih OA, Maslennikova MA, Urbanov AV, Komnov RD, Dymova OV, Eremenko AA. Successful treatment of sepsis-induced cardiomyopathy using extracorporeal membrane oxygenation and polymyxin-B endotoxin sorbtion. Klinicheskaya i eksperimental’naya hirurgiya. Zhurnal im. akad. B.V. Petrovskogo. 2019;7(3):105-117. (In Russ.). https://doi.org/10.24411/2308-1198-2019-13012